About this trial
This study evaluates the effectiveness of laser therapy versus desensitizing agents in reducing pain among participants with dentinal hypersensitivity conducted in Saidu College of Dentistry. Pain will be measured at baseline, immediately post-treatment, one week, and three months using the Visual Analog Scale (VAS)
Eligibility criteria
Qualifiers
Participants aged 18-50 years with a preoperative VAS score of ≥2 for dentinal hypersensitivity.
Participants with sensitivity due to gingival recession, cervical abrasion, or enamel erosion.
Participants with good systemic health.
Minimum of two hypersensitive teeth present in two different quadrants.
Disqualifiers
Teeth with caries, defective restorations, or cervical defects > 2 mm (may affect sensitivity measurements).
Periodontal surgery or deep periodontal pockets (> 6 mm) within the past three months (potential influence on periodontal health and sensitivity).
Participants using desensitizing toothpaste within the past three months (could interfere with study outcomes).
Presence of gross oral pathology or systemic diseases (e.g., eating disorders, chronic diseases, uncontrolled metabolic conditions) (may alter oral health status).
Trial design
Treatments tested in this trial
- Glutaraldehyde-Based Desensetizing Agent
- Low Level Laser Therapy
Treatment groups
Sponsors and collaborators
Kemia Gul
Lead sponsor
College of Physicians and Surgeons Pakistan
Sponsor institution